Synthelabo boosts sales of cardiac pacing products:
This article was originally published in Clinica
Executive Summary
Sales of French company Synthelabo's cardiac pacing products were Fr669 million ($113 million) in 1998, up 7% on a comparable basis. Earlier this month, the company launched its Brio range of single and dual-chamber cardiac pacemakers in the US. The devices use a minute ventilation sensor for rate-responsiveness, the company says. Total sales in the year were Fr12,557 million, a 7% increase.